A rapid test for bacterial sensitivity against antibiotics
To efficiently tackle clinical bacteria isolates with antibiotics, a disk diffusion assay is usually employed, which determines the minimum inhibitory concentration. However, this approach cannot distinguish between bactericidal drugs and those that only stop the growth of bacteria. Given that bacteria can develop tolerance to antibiotic treatment, there is a need for an assay to measure the survival of bacteria under antibiotics. Towards this goal, the EU-funded SurviDisk project proposes to develop a single easy-to-use low-cost assay on a disk and validate it against clinical isolates. Routine implementation of SurviDisk is expected to optimise antibiotic treatment and reduce hospitalisation times.
Fields of science
Funding SchemeERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
See on map